Search
01/06/2022
A diphtheria toxin-based nanoparticle achieves specific cytotoxic effect on CXCR4(+) lymphoma cells without toxicity in immunocompromised and immunocompetent mice
Falgàs A., Garcia-León A., Núñez Y., Serna N., Sánchez-Garcia L., Unzueta U., Voltà-Durán E., Aragó M., Álamo P., Alba-Castellón L., Sierra J., Gallardo A., Villaverde A., Vázquez E., Mangues R., Casanova I.. A diphtheria toxin-based nanoparticle achieves specific cytotoxic effect on CXCR4(+) lymphoma cells without toxicity in immunocompromised and immunocompetent mice. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2022; 150DOI:10.1016/j.biopha.2022.112940. PMID:35421785. IF:7.500(Q1/1D).
01/05/2026
KDEL-mediated modulation of intracellular trafficking in cell-targeted protein drugs
Volta-Durán, E, Alba-Castellon, L, Arena, LA, Sánchez, JM, Casanova, I, Mangues, R, Villaverde, A, Vázquez, E, Unzueta, U. KDEL-mediated modulation of intracellular trafficking in cell-targeted protein drugs. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS. 2026; 222DOI:10.1016/j.ejpb.2026.115020. PMID:41690333. IF:4.300(Q1/2D).
06/04/2026
Biomimetic Protein Materials for Adjuvant-Free Dermal Penetration
Favaro, MTP, Volta-Duran, E, Sanchez, JM, Escribano-Ferrer, E, Huaca, V, Miranda-Tovar, E, Unzueta, U, Parlade, E, Vazquez, E, Mangues, R, Villaverde, A, Casanova, I. Biomimetic Protein Materials for Adjuvant-Free Dermal Penetration. ACS Materials Letters. 2026; 8(4)DOI:10.1021/acsmaterialslett.5c01250. PMID:41982275. IF:8.700(Q1/2D).
01/12/2024
Salvage Therapy with Second-Generation Inhibitors for FLT3 Mutated Acute Myeloid Leukemia: A Real-World Study by the CETLAM and PETHEMA Groups
Vives, S, Quintela, D, Morgades, M, Cano-Ferri, I, Serrano, A, Acuña-Cruz, E, Cervera, M, Díaz-Beyá, M, Vidriales, B, Raposo-Puglia, JA, Arnan, M, Garrido, A, Balerdi, A, Cabello, AI, Herrera-Puente, P, Serrano, J, Coll, R, Tormo, M, López-Marín, J, García-Avila, S, Casado, MS, Padilla, I, Rodríguez-Macías, G, Calbacho, M, Puchol, A, Hernández, A, Torres, M, Costilla, L, Colorado, MM, Martínez-Cuadrón, D, Esteve, J, Montesinos, P. Salvage Therapy with Second-Generation Inhibitors for FLT3 Mutated Acute Myeloid Leukemia: A Real-World Study by the CETLAM and PETHEMA Groups. Cancers. 2024; 16(23)DOI:10.3390/cancers16234028. PMID:39682214. IF:4.400(Q2/3D).
01/08/2025
A Randomized Trial on Hemodynamic Optimization of Cerebral Perfusion after Successful Endovascular Therapy in Patients with Acute Ischemic Stroke (HOPE)
Camps-Renom, P, Guasch-Jiménez, M, Martinez-Domeño, A, Prats-Sánchez, L, Ramos-Pachón, A, Alvarez-Cienfuegos, J, Silva, Y, Fortea-Cabo, G, Morales-Caba, L, Rodríguez-Campello, A, Giralt-Steinhauer, E, Flores, A, Ustrell, X, López-Hernández, N, Corona-García, DJ, Freijo-Guerrero, MM, Luna, A, Tejada-Meza, H, Marta-Moreno, J, Moniche, F, Pardo-Galiana, B, Castellanos, M, Albert-Lacal, L, Sanz-Monllor, A, Aguilera-Simón, A, Marín, R, Ezcurra-Díaz, G, Lambea-Gil, A, Marti-Fàbregas, J. A Randomized Trial on Hemodynamic Optimization of Cerebral Perfusion after Successful Endovascular Therapy in Patients with Acute Ischemic Stroke (HOPE). CEREBROVASCULAR DISEASES. 2025; 54(4)DOI:10.1159/000540606. PMID:39208776. IF:1.500(Q3/8D).
01/03/2026
Early neurological deterioration before endovascular treatment in patients with mild stroke. MINORCAT-END-EVT study
Font, MA, García-Sánchez, SM, Mengual, JJ, Avellaneda, C, Boned, S, Doncel-Moriano, A, Urra, X, Camps-Renom, P, de la Ossa, NP, Terceño, M, Yugueros, B, Ustrell, X, Purroy, F, Rodríguez-Campello, A, Molina, C, Krupinski, J, Aguirre, GF, Baraldes, M, Jiménez-Fàbrega, X, Salvat-Plana, M, Elosua, R, Abilleira, S, Cardona, P, Gómez-Choco, M. Early neurological deterioration before endovascular treatment in patients with mild stroke. MINORCAT-END-EVT study. Journal of Stroke & Cerebrovascular Diseases. 2026; 35(3)DOI:10.1016/j.jstrokecerebrovasdis.2026.108584. PMID:41679406. IF:1.800(Q3/7D).